New partnership to market Optim systems.
We are pleased to announce that we entered into an agreement with Pall Corporation, a global leader in filtration, separation and purification, to sell and distribute Avacta’s market leading protein drug development tool “Optim” in South East Asia. This agreement extends Avacta’s commercial partnership with Pall, with whom the Group is already making good progress on sales and marketing of Optim in North America. Read more…
Press Room
Avacta & Pall Life Sciences agree South East Asian Alliance
Pre-close Trading Update
We have today announced the following trading update for the six month period to 31 July 2011 .
Trading update
The Company is pleased to announce that trading is in line with expectations. Underlying revenues have grown and operating losses have been reduced significantly; both are in line with market forecasts. Read more…